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Abstract
This study aimed to assess the psychometric properties of the Chinese version of the Revised Clinical 
Interview Schedule (C-CIS-R), and explore its applicability as a diagnostic instrument for common 
mental disorders (CMDs) in Hong Kong. Its psychometric properties were evaluated among 140 patients 
and 161 healthy controls. In comparison to the diagnoses made by the Structured Clinical Interview 
for the DSM-IV, the C-CIS-R showed good criterion validity in diagnosing CMDs. The correlation of 
the total score of C-CIS-R with the 12-item General Health Questionnaire and Hospital Anxiety and 
Depression Scale was satisfactory, indicating favourable convergent validity as well. The inter-rater 
and test-retest reliability were also satisfactory. Receiver operating characteristic analyses suggested an 
optimal cut-off point of 11/12 for detecting diagnosable CMDs (sensitivity: 0.69; specificity: 0.93) and 
17/18 for identifying a need for treatment (sensitivity: 0.70; specificity: 0.95). In conclusion, C-CIS-R is a 
valid diagnostic instrument for CMDs in a Chinese community. Its cut-off points for clinically significant 
symptoms and treatment needs among Chinese are identical to those adopted in the original English 
version. 
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Introduction
Common mental disorders (CMDs) such as depressive 
and anxiety disorders constitute a significant disease 
burden. They are associated with psychosocial disability,1 
poorer physical health,2 and loss of productivity.3 Apart 
from increased morbidity, CMDs also lead to significant 
mortality. In a meta-analysis of 10 prospective cohort studies 
involving 68,222 adults, those with anxiety or depressive 
disorder were found to have a reduced life expectancy.4 
Changes in mortality demonstrated a strong dose-response 
effect that remained significant after adjusting for socio-
demographic characteristics, alcohol and smoking habits, 
and social class.4
 Given their immense burden,5 there is a pressing 
need for updated prevalence data on CMDs. Large-
scale community studies, which produce generalisable 
information on prevalence, are preferred to traditional 
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of CIS-R are listed in Table 1. 
 To the best of our knowledge, there are no published 
data on the psychometric properties of the Chinese version 
of CIS-R (C-CIS-R). The present study aimed to examine 
the validity and reliability of C-CIS-R and identify its 
optimal cut-off points in the local population.
Methods
Participants
This study was conducted as preparation for the Hong 
Kong Mental Morbidity Survey, the first territory-wide 
psychiatric epidemiological study in Hong Kong.24,25 A total 
of 301 participants (140 psychiatric patients and 161 healthy 
controls) took part in the study. Patients were recruited from 
psychiatric outpatient clinics at Alice Ho Miu Ling Nethersole 
Hospital, Castle Peak Hospital, and Tuen Mun Hospital in 
Hong Kong from September 2010 to April 2011. Inclusion 
criteria comprised: (1) Chinese ethnicity, (2) age 16 to 75 
years, and (3) CMD diagnosis established by psychiatrists 
according to the ICD-10 criteria. Persons with severe mental 
illness such as schizophrenia and bipolar disorder, significant 
cognitive impairment or poor physical health were excluded. 
Age- and gender-matched control participants, who had no 
current or past psychiatric diagnosis as verified by SCID, 
were recruited from the community sources. The study 
protocol was approved by the Clinical Research Ethics 
Committees of the Chinese University of Hong Kong, the 
University of Hong Kong, and the participating hospitals. 
The study was carried out in accordance with the latest 
version of the Declaration of Helsinki.
sources of data such as psychiatric hospital admission and 
attendance records.6 Nonetheless conducting community 
surveys of psychiatric disorders was not possible until the 
1980s when fully structured diagnostic interviews started to 
emerge. The development of diagnostic interviews like the 
Diagnostic Interview Schedule,7 Composite International 
Diagnostic Interview,8 and Revised Clinical Interview 
Schedule (CIS-R)9 have made ascertainment of psychiatric 
diagnoses by trained lay interviewers in large-scale 
community studies possible.6 These structured interviews 
have contributed to the international growth in the number 
of large-scale psychiatric epidemiological studies over the 
past 2 decades.
 The CIS-R is one of the most widely used structured 
diagnostic assessments for CMDs. Developed from the 
Clinical Interview Schedule,10 CIS-R has demonstrated 
concordance with the Schedules for Clinical Assessment in 
Neuropsychiatry11 and the Structured Clinical Interview for 
the DSM-IV (SCID).12 Compared with other fully structured 
diagnostic interviews, CIS-R requires less administration 
time, is user-friendly for lay interviewers, and is highly 
acceptable to the respondents. It retains adequate validity in 
assessing depressive and anxiety disorders in different age 
and ethnic minority groups.13,14
 To further its use in large-scale psychiatric 
epidemiological studies, the CIS-R has been translated 
into various languages. Its original and translated versions 
have been used in European countries (United Kingdom, 
Greece, Italy, Romania, Spain, and France)11,12,15-17 and 
beyond (Australia, Sri Lanka, Malaysia, Brazil, Tanzania, 
and Zimbabwe).18-23 Validation studies of various versions 
Table 1. Validity studies of the Revised Clinical Interview Schedule in previous reports.
Abbreviations: CMD = common mental disorder; Sen = sensitivity; Sp = specificity.
Author (year) Country Setting Age 
(years)
No. of 
patients
Cut-off Depressive disorder Anxiety disorder Any CMD Symptom group
Sen Sp Kappa Sen Sp Kappa Sen Sp Kappa Kappa
Pez et al (2010)12 Italy Primary care clinic 18+ 120 – 0.27 1.00 0.39 0.35 0.93 0.34 0.38 0.95 0.39 –
Pez et al (2010)12 Romania Primary care clinic 18+ 120 – 0.33 0.96 0.35 0.29 0.91 0.23 0.33 0.91 0.28 –
Pez et al (2010)12 Spain Primary care clinic 18+ 119 – 0.38 0.95 0.30 0.37 0.95 0.37 0.44 0.93 0.40 –
Pez et al (2010)12 France Primary care or specialist clinic 18+ 141 – 0.33 0.99 0.43 0.22 0.88 0.07 0.29 0.89 0.16 –
Subramaniam et al (2006)20 Malaysia Psychiatric hospital 16+ 59 8/9 – – 0.88 0.96 – –
Taub et al (2005)15 UK General population 16-74 612 – 0.35 0.95 0.28 0.49 0.87 0.23 0.63 0.88 0.39 –
Jordanova et al (2004)11 UK Primary care clinic 16-65 105 11/12 0.38 0.93 0.27 0.45 0.99 0.52 0.41 0.97 0.41 –
Wickramasinghe et al (2002)19 Sri Lanka Psychiatric clinic 15-19 131 – – – – Overall agreement 0.11-0.88
Brugha et al (1999)16 UK General population 16-64 205 – 0.31 0.94 0.23 0.46 0.86 0.26 0.49 0.81 0.25 –
Patton et al (1999)18 Australia General population 14-15 157 – 0.18 0.97 – – – –
Patel and Mann (1997)23 Zimbabwe Primary care clinic 16-65 302 11/12 – – Overall agreement 55% –
Botega et al (1995)21 Brazil General hospital 14-81 78 – – – – Overall agreement 0.47-0.80
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Instruments
The CIS-R9 determines the presence of 14 non-psychotic 
symptoms in the past week, namely somatic symptoms, 
fatigue, concentration and forgetfulness, sleep problems, 
irritability, worry about physical health, depression, 
depressive ideas, worry, anxiety, phobias, panic, 
compulsions, and obsessions. Score for each symptom 
section ranges from 0 to 4 (except for 0-5 for depressive 
ideas). The total score of CIS-R indicates the overall 
severity of psychological symptoms. The ICD-10 diagnoses 
of CMDs, including depressive episode, generalised anxiety 
disorder, mixed anxiety and depressive disorder, phobias, 
panic disorder, and obsessive-compulsive disorder, can 
be derived from a standard algorithm based on the CIS-R 
responses.
 Chinese-bilingual SCID is a semi-structured clinical 
interview designed to generate a psychiatric diagnosis. It 
is well validated and extensively used in the local Chinese 
population with an overall kappa for inter-rater reliability of 
0.84 and rater-clinician reliability of 0.77.26,27 In the present 
study, modules A and D (mood disorders) and F (anxiety 
disorders) were administered to participants.
 The 12-item General Health Questionnaire (GHQ-
12)28 is a self-administered questionnaire that measures 
general mental health in both clinical and community 
settings. Each item is rated on a 4-point scale with a 
higher score representing greater psychological distress. 
The Chinese version gives satisfactory sensitivity and 
specificity.29
 The Hospital Anxiety and Depression Scale 
(HADS)30 includes 14 questions probing depression and 
anxiety. Each question is scored on a 4-point scale from 0 
to 3, with a higher score representing a higher frequency of 
occurrence of a symptom. The scale includes 7 questions 
related to depression and 7 to anxiety. Score for each 
domain ranges from 0 to 21, with a maximum total score 
of 42. The Chinese version demonstrates good validity and 
reliability for screening psychiatric morbidity in the local 
population.31
 The Social and Occupational Functioning Assessment 
Scale (SOFAS)32 measures overall social and occupational 
functioning of an individual due to their physical limitations, 
general medical condition, and mental impairment. The 
global rating ranges from 0 to 100, where higher score 
indicates better functioning. 
Procedures
Forward and Backward Translation
The CIS-R questionnaire was first translated into Chinese 
then back-translated into English by 2 independent teams 
of mental health professionals. To ensure conceptual 
equivalence, the teams comprised experienced bilingual 
psychologists and psychiatrists who had no prior knowledge 
of the scale. A consensus Chinese version was developed 
by comparing the original and back-translated versions. 
Disagreement and reconciliation were discussed in a focus 
group involving the principal investigator, translators, and 
psychiatrists in the research team. The consensus version 
was pilot tested in a sample of 5 patients (3 depression and 
2 anxiety), and the questionnaire further refined as the final 
version of C-CIS-R. 
Author (year) Country Setting Age 
(years)
No. of 
patients
Cut-off Depressive disorder Anxiety disorder Any CMD Symptom group
Sen Sp Kappa Sen Sp Kappa Sen Sp Kappa Kappa
Pez et al (2010)12 Italy Primary care clinic 18+ 120 – 0.27 1.00 0.39 0.35 0.93 0.34 0.38 0.95 0.39 –
Pez et al (2010)12 Romania Primary care clinic 18+ 120 – 0.33 0.96 0.35 0.29 0.91 0.23 0.33 0.91 0.28 –
Pez et al (2010)12 Spain Primary care clinic 18+ 119 – 0.38 0.95 0.30 0.37 0.95 0.37 0.44 0.93 0.40 –
Pez et al (2010)12 France Primary care or specialist clinic 18+ 141 – 0.33 0.99 0.43 0.22 0.88 0.07 0.29 0.89 0.16 –
Subramaniam et al (2006)20 Malaysia Psychiatric hospital 16+ 59 8/9 – – 0.88 0.96 – –
Taub et al (2005)15 UK General population 16-74 612 – 0.35 0.95 0.28 0.49 0.87 0.23 0.63 0.88 0.39 –
Jordanova et al (2004)11 UK Primary care clinic 16-65 105 11/12 0.38 0.93 0.27 0.45 0.99 0.52 0.41 0.97 0.41 –
Wickramasinghe et al (2002)19 Sri Lanka Psychiatric clinic 15-19 131 – – – – Overall agreement 0.11-0.88
Brugha et al (1999)16 UK General population 16-64 205 – 0.31 0.94 0.23 0.46 0.86 0.26 0.49 0.81 0.25 –
Patton et al (1999)18 Australia General population 14-15 157 – 0.18 0.97 – – – –
Patel and Mann (1997)23 Zimbabwe Primary care clinic 16-65 302 11/12 – – Overall agreement 55% –
Botega et al (1995)21 Brazil General hospital 14-81 78 – – – – Overall agreement 0.47-0.80
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generated by C-CIS-R and SCID using kappa coefficients 
(κ) with standard errors. Spearman’s correlations between 
total scores of GHQ-12, HADS, and C-CIS-R were 
calculated in the patient group (n = 140) to determine the 
convergent validity. Internal consistency of questions in 
each symptom section was measured by Cronbach’s alpha. 
Intraclass correlation coefficients (ICC) of the C-CIS-R 
total score were computed for inter-rater and test-retest 
reliability. Two receiver operating characteristic (ROC) 
curves (sensitivity vs. 1-specificity) were generated. The 
first ROC curve was constructed to identify the optimal 
cut-off score for significant non-psychotic symptoms (i.e. 
diagnosable CMDs). By including patients and healthy 
controls in the analysis, the score that best differentiated 
those with CMDs from those without was decided using 
the patient-control criterion. The second ROC curve 
determined the cut-off score for symptoms that require 
clinical attention. As the vast majority of CMD patients 
in need of treatment suffer impaired function and had an 
Validity and Reliability
The Chinese versions of CIS-R, GHQ-12, and HADS were 
evaluated by research assistants who underwent video 
training and supervised administration of the instruments. 
Psychiatrists who were blinded to previous assessment 
results then conducted SCID interviews to establish 
psychiatric diagnoses. All psychiatrists had more than 
5 years of clinical experience and received training on 
SCID. The inter-rater reliability of C-CIS-R was evaluated 
by observer co-ratings of a random subsample of 35 
participants. For test-retest reliability of C-CIS-R, another 
random subsample of 24 participants was reassessed by the 
same rater 2 weeks later. 
Statistical Analyses
Statistical analyses were performed using STATA version 
12.0 (StataCorp). Descriptive statistics were expressed as 
means, with standard deviations, percentages, or ranges. 
Criterion validity was evaluated by comparing diagnoses 
Table 2. Demographic characteristics of the study sample.*
Patients with any common mental 
disorder (n = 140)
Healthy controls (n = 161)
Age (years) 47.5 ± 13.3 47.5 ± 13.9
Gender
Male 47 (33.6) 57 (35.4)
Female 93 (66.4) 104 (64.6)
Educational level
No schooling or primary 43 (30.7) 30 (18.6)
Lower secondary 30 (21.4) 19 (11.8)
Upper secondary 51 (36.4) 58 (36.0)
Post-secondary 16 (11.4) 54 (33.5)
Marital status
Single 31 (22.1) 40 (24.8)
Married or cohabiting 68 (48.6) 110 (68.3)
Divorced or separated 32 (22.9) 4 (2.5)
Widowed 9 (6.4) 7 (4.3)
Employment status
Working 44 (31.4) 112 (69.6)
Retired 13 (9.3) 22 (13.7)
Housewife 38 (27.1) 15 (9.3)
Student 4 (2.9) 10 (6.2)
Unemployed or not working 41 (29.3) 2 (1.2)
Diagnoses by clinician†
Major depressive disorder 52 (37.1) -
Generalised anxiety disorder 38 (27.1) -
Panic disorder 13 (9.3) -
Phobias 29 (20.7) -
Obsessive-compulsive disorder 14 (10.0) -
Mixed anxiety and depressive disorder 6 (4.3) -
* Data are shown as mean ± standard deviation or No. (%) of subjects.
† Psychiatric diagnoses of healthy controls were verified by Structured Clinical Interview for the DSM-IV.
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SOFAS score of ≤ 70,33 we defined the group needing 
clinical treatment as participants with SOFAS score of ≤ 70 
when determining the corresponding threshold. Area under 
the curve (AUC)34 was computed for each ROC curve. 
Sensitivity, specificity, positive predictive value (PPV), 
negative predictive value (NPV), and percentage of correct 
classification were compared across different cut-off points. 
The level of significance was set at two-sided p < 0.05.
Results
Validity and Reliability
Table 2 presents the demographic characteristics of the 140 
patients and 161 healthy controls. Their mean (± standard 
deviation) age was 47.4 ± 13.6 years. Of them, 104 (34.6%) 
were men and 197 (65.4%) women. Among the patients, 
60.7% had a current psychiatric disorder as confirmed 
by SCID (29.3% with depressive disorders, 40.7% with 
anxiety disorders). The criterion validity of C-CIS-R, 
as evident from the association between C-CIS-R– and 
SCID-generated diagnoses, was moderate (Table 3). Kappa 
values linking C-CIS-R– and SCID-generated diagnoses of 
depressive disorder, anxiety disorder, and any CMD were 
0.68 (standard error, 0.06), 0.41 (0.06) and 0.67 (0.05), 
respectively.
 The convergent validity of C-CIS-R was determined 
by its correlation with GHQ-12 and HADS scores in the 
patient group (n = 140). There was a significant and sizeable 
correlation between the C-CIS-R and GHQ-12 (r = 0.71, 
p < 0.001). The correlation between the C-CIS-R and 
HADS was also significant (r = 0.76, p < 0.001). 
 The internal consistency was high with Cronbach’s 
alpha ranging from 0.685 to 0.931 in all sections. The inter-
rater and test-retest reliability of the C-CIS-R were both 
satisfactory, in which the ICC were 0.997 (p < 0.001) and 
0.894 (p < 0.001) respectively. 
Optimal Cut-off Points
Receiver operating characteristic curve analyses were 
performed to determine the threshold points for the C-
CIS-R. To detect significant non-psychotic symptoms (i.e. 
diagnosable CMDs) in the patient group, an ROC curve with 
AUC of 0.810 was constructed (Fig 1). A cut-off score of 
≥ 12 gave an optimal sensitivity of 69.3% (95% confidence 
interval [CI], 60.9-76.8%) and specificity of 92.7% (95% 
CI, 87.6-96.2%). 
 To identify those participants who needed clinical 
attention (i.e. SOFAS score ≤ 70), an ROC curve with an 
AUC of 0.827 was constructed (Fig 2). A cut-off score 
≥ 18 gave a sensitivity of 70.2% (95% CI, 59.9-79.2%) and 
Table 3. Criterion validity of C-CIS-R.
Abbreviations: C-CIS-R = Chinese version of the Revised Clinical Interview Schedule; CMD = common mental disorder; NPV = 
negative predictive value; PPV = positive predictive value.
* Any CMD means depressive disorder or anxiety disorder or both.
Figure 1.  Receiver operating characteristic curve 
in detecting diagnosable common mental disorders 
(CMDs).
Abbreviation: C-CIS-R = Chinese version of the Revised 
Clinical Interview Schedule.
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Figure 2.  Receiver operating characteristic curve in 
detecting symptoms that require clinical attention.
Abbreviation: C-CIS-R = Chinese version of the Revised 
Clinical Interview Schedule.
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Table 4. Diagnostic accuracy for various cut-off points of C-CIS-R in detecting diagnosable CMDs and symptoms that 
require clinical attention.
C-CIS-R cut-off point Sensitivity (%) Specificity (%) PPV (%) NPV (%)
Detecting diagnosable CMDs
10
11
12
13
14
15
75.7
72.1
69.3
67.9
64.3
58.6
89.6
89.6
92.7
93.9
97.0
97.0
86.9
86.3
89.0
90.5
94.7
94.3
80.8
78.6
77.9
77.4
76.1
73.3
Detecting the need for clinical attention
16
17
18
19
20
73.4
71.3
70.2
66.0
64.9
91.9
93.3
95.2
96.2
97.1
80.2
82.7
86.8
88.6
91.0
88.5
87.9
87.7
86.3
86.1
Abbreviations: C-CIS-R = Chinese version of the Revised Clinical Interview Schedule; CMDs = common mental disorders; NPV = 
negative predictive value; PPV = positive predictive value.
specificity of 95.2% (95% CI, 91.4-97.7%). The diagnostic 
accuracy at different cut-off points is listed in Table 4.
Discussion
In view of the significant morbidity and mortality 
associated with CMDs,1-4 it is important for mental health 
providers to offer early identification and treatment for 
people with depressive and anxiety disorders. Developing 
validated structured diagnostic instruments for CMDs is 
therefore essential. It allows conduction of psychiatric 
epidemiological studies that provide accurate prevalence 
data of mental health problems in the community, and 
facilitates appropriate planning of service and formulation 
of mental health policies.
 This paper reports the first study of the psychometric 
properties of the C-CIS-R. Compared with previous validity 
studies (Table 1), the overall agreement between C-CIS-R 
and SCID in our study was either fair or moderate (κ = 
0.68 for depression, 0.41 for anxiety disorders and 0.67 for 
any disorder). The capacity of C-CIS-R to predict SCID-
generated diagnoses was moderate to good. It performed 
well in identifying depression and any disorder (PPV = 
66% and 69.4%, respectively) and moderately so for 
anxiety disorders (PPV = 44.9%). The high NPV of above 
90% for any disorder also indicates the accurate detection 
of most non-CMD cases in the community. In addition, the 
C-CIS-R showed good convergent validity with GHQ-12 
and HADS, and demonstrated excellent inter-rater and test-
retest reliability.
 The cut-off points of 11/12 indicated the presence 
of diagnosable CMDs and 17/18 a need for treatment and 
clinical attention. At both points, high specificity (11/12: 
92.7% and 17/18: 95.2%) and moderate sensitivity (around 
70%) were achieved. They concurred with the threshold 
points reported in the Adult Psychiatric Morbidity Survey 
in the United Kingdom.35
 The strength of our study was the use of SCID, a 
gold standard in establishing psychiatric diagnosis, when 
validating the psychometric properties of C-CIS-R. Another 
Hong Kong Mental Morbidity Survey
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strength of the study is the examination of a wide array of 
CMDs of different severities among psychiatric patients. 
Nonetheless there are a number of limitations worth noting. 
Firstly, the use of the self-reported questionnaires might 
render the results subject to recall bias. Second, the optimal 
cut-off points might differ with respect to age and gender, 
and were not investigated in the current study. The scale was 
also not tested on patients with severe psychiatric problems 
such as schizophrenia, major neurocognitive disorders, or 
substance use disorders. Finally, the study did not collect 
information on co-morbidity with physical illnesses and 
mental disorders other than CMDs. Further investigation is 
required to study the generalisability of our findings to other 
cohorts. Despite these limitations, the current study provides 
the first-ever evidence that the psychometric properties of 
C-CIS-R are satisfactory, and similar to CIS-R in other 
languages. This confirms the applicability of C-CIS-R as a 
diagnostic instrument of CMDs in Chinese communities.
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